Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of IMOD to HAART in HIV-positive patients
IRCT2015070423046N1Phase 3Completed
- Sponsor
- Islamic Azad University Qom Branch
- Start
- Aug 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of IMOD in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS), sponsored by Islamic Azad University Qom Branch. Started Aug 2013; status: completed.
02
Drugs
IMOD
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on IRCT2015070423046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015070423046N1.